Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

FIRVANQ

×

Overview

What is FIRVANQ?

FIRVANQ™ for oral administration contains the hydrochloride salt of vancomycin, a tricyclic glycopeptide antibiotic derived from (formerly ), which has the chemical formula CHClNO•HCl. The molecular weight of vancomycin hydrochloride is 1485.71 g/mol.

Vancomycin hydrochloride has the structural formula:

Each FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 3.

The Grape-Flavored Diluent used to reconstitute the oral solution contains: artificial grape flavor, citric acid (anhydrous), D&C Yellow No. 10, FD&C Red No. 40, purified water, sodium benzoate and sucralose.



What does FIRVANQ look like?



What are the available doses of FIRVANQ?

Each FIRVANQ™ kit contains: vancomycin hydrochloride USP, powder for oral solution, equivalent to 3.75 g, 7.5 g or 15 g vancomycin, and Grape-Flavored Diluent. ()

What should I talk to my health care provider before I take FIRVANQ?

Geriatrics

5.3

6.1

8.5

14.1

How should I use FIRVANQ?

FIRVANQ™ is indicated for the treatment of e-associated diarrhea in adults and pediatric patients less than 18 years of age.

FIRVANQ™ is also indicated for the treatment of enterocolitis caused by (including methicillin-resistant strains) in adults and pediatric patients less than 18 years of age.

Important

Limitations of Use

To reduce the development of drug-resistant bacteria and maintain the effectiveness of FIRVANQ™ and other antibacterial drugs, FIRVANQ™ should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Prior to oral administration, the supplied FIRVANQ™ powder must be reconstituted by the healthcare provider (i.e., a pharmacist) to produce the oral solution [ ].


What interacts with FIRVANQ?

Sorry No Records found


What are the warnings of FIRVANQ?

Sorry No Records found


What are the precautions of FIRVANQ?

Sorry No Records found


What are the side effects of FIRVANQ?

Sorry No records found


What should I look out for while using FIRVANQ?

FIRVANQ™ is contraindicated in patients with known hypersensitivity to vancomycin.


What might happen if I take too much FIRVANQ?

Supportive care is advised, with maintenance of glomerular filtration. Vancomycin is poorly removed by dialysis. Hemofiltration and hemoperfusion with polysulfone resin have been reported to result in increased vancomycin clearance.

For current information on the management of overdosage, contact the National Poison Control Center at 1-800-222-1222 or www.poison.org.


How should I store and handle FIRVANQ?

How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].How SuppliedEach FIRVANQ™ kit contains a bottle of vancomycin hydrochloride USP, as white to almost white or tan to brown powder for oral solution, and a bottle of pre-measured Grape-Flavored Diluent, in the strengths and volumes listed in Table 5.Storage and HandlingStore FIRVANQ™ prior to reconstitution at refrigerated conditions, 2°C to 8°C (36°F to 46°F).Do not freeze. Keep container tightly closed. Protect from light.Store reconstituted solutions of FIRVANQ™ at 2°C to 8°C [ ].


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Vancomycin is an antibacterial drug [ ].

Non-Clinical Toxicology
FIRVANQ™ is contraindicated in patients with known hypersensitivity to vancomycin.

Drug-drug interactions can be pharmacodynamic (combined pharmacologic effects) or pharmacokinetic (alteration of plasma levels). The risks of using haloperidol in combination with other drugs have been evaluated as described below.

FIRVANQ™ must be given orally for treatment of -associated diarrhea and staphylococcal enterocolitis. Orally administered vancomycin is not effective for treatment of other types of infections.

Parenteral administration of vancomycin is effective for treatment of -associated diarrhea and staphylococcal enterocolitis. If parenteral vancomycin therapy is desired, use an intravenous preparation of vancomycin and consult the package insert accompanying that preparation.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).